Breaking The Big Pharma Monopoly
The spread of bird flu has the world poised for a pandemic. Fearing a shortfall of the most effective antiviral treatment, calls are growing for the patent to be lifted, adding fuel to the debate on generics manufacturing. WHO’s Klaus Stöhr tells Jim Banks why the fight over patents is going to get even tougher. more..
|
Keeping innovation on the Agenda
Leading pharma companies and emerging biotechs are keen to operate from Canada, AstraZeneca’s William Charnetski and Industry Canada’s Dr George Michaliszyn tell Jim Banks. With the Canadian Government looking to further encourage R&D, the country will remain a key player in the global pharma market. more.. |
Drugs, Lies and Regulations
regulations Pharmaceutical counterfeiting is increasing, potentially putting the safety, possibly lives, of millions of patients at risk. Julian Mount, senior director at Pfizer, explains what his company is doing to ensure and enhance patient safety. more.. |
Six Sigma and The road To Success
Dr Ingolf Stückrath of sanofi aventis discusses how his site successfully implemented the Six Sigma methodology as a tool for efficient manufacturing in the twenty-first century. more..
Read more on 'Manufacturing' by key suppliers
|
Building the Bigger Picture
The Society for Biomolecular Sciences’ president, Dr Dejan Bojanic, talks to Will Ollard about how the organisation’s role has changed from specialising in HTS to advancing the entire
science of drug discovery. more..
Read more on 'Drug Discovery & Development' by key suppliers |
Generics size up Market Opportunity
While the market for original brands slowed in 2005, sales of generics have gone from strength to strength. Eva Edery, IMS Global Pharma Strategy, offers new insights on this growing sector. more.. |
Simplifying compliance
Implementing compliance regulations can be a costly and time-consuming process. NNIT’s Bjarne Wiboe explains how his team created an ERP system
where compliance can be achieved cost-effectively and without risks. more..
Read more on 'Regulatory & Compliance' by key suppliers
|
Talking about an SMM revolution?
The use of small-molecule micro-arrays is set to make a huge impact in drug discovery. Dr Nicholas Westwood and Stephen Patterson of St Andrews University, discuss its potential. more..
|
Offshoring Within Pharma
Nick Trythall, associate director development operations with Pfizer UK, discusses the strategy and operational implementation of offshoring within the drug development environment. more..
|
